查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423201

2024-2032 年生物植入物市场报告（按生物植入物类型、材料、原产地、管理模式、最终用户和地区）

Bio-Implants Market Report by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2023年全球生物植入物市场规模达1,268亿美元。展望未来， IMARC Group预计到2032年市场规模将达到2,427亿美元，2024-2032年复合年增长率（CAGR）为7.3%。全球老年人口不断增加，生物材料、3D 列印和组织工程等医疗技术不断进步，以及患者对生物植入物益处的认识不断提高，是推动该市场的一些主要因素。

生物植入物，也称为生物医学植入物或医学植入物，是透过手术植入体内以替代、支持或增强生物结构或功能的装置或材料。这些植入物旨在与活体组织相互作用，促进整合和相容性，以实现特定的医疗目标。生物植入物在其组成、目的和应用方面存在很大差异。它们通常用于各种医学领域，包括骨科、心臟病学、牙科、神经病学和美容外科。它们还可以替换受损或功能失调的身体部位或结构。例如，关节置换术（例如髋关节或膝关节植入物）用于恢復关节退化患者的活动能力并减轻疼痛。

不断增加的老年人口主要推动市场，因为他们经常需要针对各种健康状况进行医疗干预。生物植入物，例如关节置换和牙科植入物，在恢復老年人的活动能力和提高生活品质方面发挥关键作用。此外，生物材料、3D 列印和组织工程等医疗技术的不断进步，使得创新和复杂的生物植入物的开发成为可能。这些技术提高了植入物的耐用性、功能性和生物相容性。此外，心血管疾病、糖尿病和骨科疾病等慢性疾病的日益普及也增加了对生物植入物的需求。这些植入物通常用于治疗、復健和恢復正常身体功能。此外，患者对生物植入物的好处及其在改善健康结果方面的有效性的认识不断提高，导致对这些医疗设备的接受度和需求不断增加。

生物植入物市场趋势/驱动因素：

世界各地老年人口不断增加

全球老年人口的成长是推动生物植入物市场成长的重要驱动力。随着老年人口的增加，关节退化、心血管疾病和牙齿问题等与年龄相关的疾病的盛行率也随之上升。生物植入物透过提供关节置换、心臟植入物和假牙等解决方案，在解决这些问题方面发挥着至关重要的作用。因此，提高老年人的生活品质和恢復功能独立性的需求推动了对生物植入物的需求，从而促进了市场的扩张。此外，随着医疗技术的进步，这些植入物变得越来越复杂、耐用，并且可以根据患者的个人需求量身定制。因此，老年人更倾向于选择生物植入物来增强身体和功能能力。

医疗技术不断进步

生物材料、3D列印和组织工程等医疗技术的不断进步是推动生物植入物市场成长的关键因素。生物材料的创新促进了生物相容性和耐用性增强的植入物的开发，降低了不良反应的风险。 3D 列印可精确客製化植入物，改善患者特定的治疗效果并减少手术併发症。此外，组织工程技术为创建可与身体组织无缝整合的生物功能植入物开闢了途径。这些技术进步扩大了生物植入物的应用和有效性，吸引了医疗保健专业人员和寻求先进和客製化医疗解决方案的患者。

患者对生物植入物益处的认识不断提高

提高患者对生物植入物益处的认识是推动市场成长的关键驱动力。患者越来越了解生物植入物恢復正常身体功能、减轻疼痛和提高整体生活品质的潜力。透过网路和医疗保健活动获取讯息，患者正在积极寻求为他们的医疗状况提供长期解决方案的替代方案。透过生物植入获得积极成果的个人的成功故事正在影响其他人考虑这些干预措施。这种意识的提高不仅提高了患者的接受度，还鼓励医疗保健提供者推荐生物植入物作为可行的治疗选择，有助于市场的扩大。此外，患者意识的不断增强促使医疗保健专业人员将生物植入作为其治疗建议的一部分。医生越来越多地考虑将生物植入物作为各个专业的有效治疗选择。患者利益和医疗认可之间的这种一致性创造了一个积极的反馈循环，推动生物植入物的更多采用并促进市场成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物植入物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：依生物植入物类型
  • 市场区隔：按材料
  • 市场区隔：按产地
  • 市场区隔：依管理模式
  • 市场区隔：按最终用户
  • 市场区隔：按地区
  • 市场预测

第 6 章：市场细分：依生物植入物类型

  • 心血管植入物
    • 市场走向
    • 市场预测
  • 植牙
    • 市场走向
    • 市场预测
  • 脊椎生物植入物
    • 市场走向
    • 市场预测
  • 骨科植入物
    • 市场走向
    • 市场预测
  • 眼科植入物
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依材料

  • 金属色
    • 市场走向
    • 市场预测
  • 陶瓷製品
    • 市场走向
    • 市场预测
  • 聚合物
    • 市场走向
    • 市场预测
  • 生物
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依来源地

  • 同种异体移植物
    • 市场走向
    • 市场预测
  • 自体移植物
    • 市场走向
    • 市场预测
  • 异种移植
    • 市场走向
    • 市场预测
  • 合成的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按管理模式

  • 非手术
    • 市场走向
    • 市场预测
  • 外科
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 医院
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 12 章：全球生物植入物产业：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：全球生物植入物产业：价值链分析

  • 概述
  • 研究与开发
  • 原物料采购
  • 製造业
  • 行销
  • 分配
  • 最终用途

第 14 章：全球生物植入物产业：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：全球生物植入物产业：价格分析

  • 价格指标
  • 价格结构
  • 利润分析

第 16 章：生物植入物製造过程

  • 产品概述
  • 原料要求
  • 製造流程
  • 关键成功因素与风险因素

第17章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Stryker Corporation
    • St. Jude Medical Inc
    • Medtronic Inc.
    • Smith and Nephew
    • Wright Medical Group
    • Zimmer Biomet
    • Dentsply Sirona
    • Invibio Limited
    • Straumann
    • Danaher Corporation
    • Cardinal Health
    • Johnson & Johnson
    • B. Braun Melsungen
    • LifeNet Health, Inc
    • Endo International plc
Product Code: SR112024A1162

Abstract

The global bio-implants market size reached US$ 126.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 242.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. The rising geriatric population around the world, constant advancements in medical technology, including biomaterials, 3D printing, and tissue engineering, and the growing awareness among patients about the benefits of bio-implants are some of the major factors propelling the market.

Bio-implants, also known as biomedical implants or medical implants, are devices or materials that are surgically implanted into the body to replace, support, or enhance a biological structure or function. These implants are designed to interact with living tissues, promoting integration and compatibility to achieve specific medical objectives. Bio-implants can vary widely in terms of their composition, purpose, and applications. They are commonly used in various medical fields, including orthopedics, cardiology, dentistry, neurology, and cosmetic surgery. They can also replace damaged or dysfunctional body parts or structures. For instance, joint replacements (such as hip or knee implants) are used to restore mobility and alleviate pain in individuals with joint degeneration.

The increasing geriatric population is primarily driving the market as they often require medical interventions for various health conditions. Bio-implants, such as joint replacements and dental implants, play a critical role in restoring mobility and enhancing quality of life for older adults. In addition, constant advancements in medical technology, including biomaterials, 3D printing, and tissue engineering, have enabled the development of innovative and sophisticated bio-implants. These technologies lead to improved implant durability, functionality, and biocompatibility. Moreover, the growing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders is also escalating the demand for bio-implants. These implants are often required for treatment, rehabilitation, and restoration of normal bodily functions. Moreover, growing awareness among patients about the benefits of bio-implants and their effectiveness in improving health outcomes has led to greater acceptance and demand for these medical devices.

Bio-Implants Market Trends/Drivers:

Rising geriatric population around the world

The global rise in the geriatric population is a significant driver fueling the growth of the bio-implants market. As the elderly population increases, the prevalence of age-related medical conditions such as joint degeneration, cardiovascular diseases, and dental issues also rises. Bio-implants play a vital role in addressing these conditions by providing solutions like joint replacements, cardiac implants, and dental prosthetics. As a result, the need to enhance the quality of life and restore functional independence among seniors drives the demand for bio-implants, contributing to market expansion. Moreover, with advancements in medical technology, these implants are becoming increasingly sophisticated, durable, and tailored to individual patient needs. As a result, the elderly population is more inclined to opt for bio-implants to enhance their physical and functional capabilities.

Constant advancements in medical technology

The continuous progress in medical technology, encompassing biomaterials, 3D printing, and tissue engineering, is a pivotal factor driving the growth of the bio-implants market. Innovations in biomaterials have led to the development of implants with enhanced biocompatibility and durability, reducing the risk of adverse reactions. 3D printing enables precise customization of implants, improving patient-specific outcomes and reducing surgical complications. Moreover, tissue engineering techniques have opened avenues for creating biologically functional implants that can integrate seamlessly with the body's tissues. These technological advancements have expanded the applications and effectiveness of bio-implants, attracting both healthcare professionals and patients seeking advanced and tailored medical solutions.

Growing awareness among patients about the benefits of bio-implants

Increasing patient awareness about the benefits of bio-implants is a key driver propelling market growth. Patients are becoming more informed about the potential of bio-implants to restore normal bodily functions, alleviate pain, and enhance overall quality of life. With access to information through the internet and healthcare campaigns, patients are actively seeking alternatives that offer long-term solutions to their medical conditions. The success stories of individuals who have experienced positive outcomes with bio-implants are influencing others to consider these interventions. This heightened awareness has not only boosted patient acceptance but also encouraged healthcare providers to recommend bio-implants as viable treatment options, thereby contributing to the expansion of the market. Furthermore, the growing awareness among patients has prompted healthcare professionals to include bio-implants as part of their treatment recommendations. Medical practitioners are increasingly considering bio-implants as effective therapeutic options across various specialties. This alignment between patient interest and medical endorsement creates a positive feedback loop, driving greater adoption of bio-implants and contributing to market growth.

Bio-Implants Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global bio-implants market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on type of bio-implants, material, origin, mode of administration and end user.

Breakup by Type of Bio-Implants:

Cardiovascular Implants

Dental Implants

Spinal Bio-implants

Orthopaedic Implants

Ophthalmic Implants

Others

Orthopaedic implants represent the most used type of bio-implant

The report has provided a detailed breakup and analysis of the market based on the type of bio-implants. This includes cardiovascular implants, dental implants, spinal bio-implants, orthopaedic implants, ophthalmic implants and others. According to the report, orthopaedic implants represented the largest segment.

Orthopedic implants are widely used to address a range of musculoskeletal disorders, including joint degeneration, fractures, and bone deformities. The prevalence of conditions such as osteoarthritis and fractures, especially among the aging population, drives the demand for orthopedic implants. Moreover, they offer patients the ability to regain mobility, reduce pain, and improve overall functionality. This positive impact on patients' quality of life encourages greater acceptance of orthopedic implant procedures. Besides, constant advancements in orthopedic implant technology, including improved biomaterials, design innovation, and minimally invasive surgical techniques, have made orthopedic procedures more effective and patient-friendly. These advancements contribute to the widespread use and success of orthopedic implants.

Breakup by Material:

Metallic

Ceramic

Polymer

Biological

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes metallic, ceramic, polymer and biological.

Metallic implants are widely utilized in various medical applications due to their strength, durability, and compatibility with the human body. Materials like titanium and stainless steel are commonly used for joint replacements, orthopedic implants, and dental fixtures. Metallic implants offer excellent load-bearing capabilities, making them suitable for weight-bearing structures within the body.

Ceramic implants are known for their biocompatibility, resistance to wear, and ability to closely mimic natural tissues. Materials such as alumina and zirconia are often used for dental implants and joint replacements. They are valued for their aesthetic appeal, as they can resemble natural teeth and bones, enhancing patient satisfaction.

Polymer implants are lightweight and can be tailored to specific requirements. They are commonly used in non-weight-bearing applications, such as soft tissue repair, cardiovascular devices, and cosmetic enhancements. Polymers like polyethylene and polyurethane are chosen for their flexibility, corrosion resistance, and ability to minimize stress on surrounding tissues.

Biological implants involve the use of tissues or cells sourced from human or animal donors. These implants include materials like allografts (donor tissues), xenografts (animal tissues), and autografts (the patient's own tissues). These implants are utilized for grafts, transplants, and regenerative procedures. They offer the advantage of potentially seamless integration with the patient's body.

Breakup by Origin:

Allograft

Autograft

Xenograft

Synthetic

Xenograft accounts for the majority of market share

A detailed breakup and analysis of the market based on the origin has also been provided in the report. This includes allograft, autograft, xenograft and synthetic. According to the report, xenograft accounted for the largest market share.

Xenografts benefit from a readily available and sustainable supply of biological tissues, primarily sourced from animals such as pigs and cows. This abundant supply helps meet the demand for bio-implants without significant limitations, which can be particularly advantageous when addressing large patient populations. Moreover, they are processed to reduce the risk of immune rejection and adverse reactions when implanted in humans. While some immune response mitigation might still be necessary, advancements in processing techniques have significantly improved xenograft biocompatibility, making them suitable for a wide range of applications. Besides, xenografts often offer cost-effective solutions compared to other types of bio-implants, making them an attractive option for both patients and healthcare systems seeking high-quality medical interventions without exorbitant costs.

Breakup by Mode of Administration:

Non-Surgical

Surgical

A detailed breakup and analysis of the market based on the mode of administration has also been provided in the report. This includes non-surgical and surgical.

Non-surgical bio-implants involve methods of implantation that do not require invasive surgical procedures. Instead, they often rely on minimally invasive techniques or external applications. Examples of non-surgical bio-implants include wearable medical devices, such as insulin pumps for diabetes management or hearing aids for auditory support. These devices are designed to be worn or attached externally to the body and can provide continuous monitoring, drug delivery, or functional enhancement without the need for surgical intervention.

Surgical bio-implants involve procedures that require a surgical incision to place the implant directly within the body. These types of implants are commonly used for structural support, replacement, or enhancement of biological tissues or organs. Surgical bio-implants encompass a wide range of applications, including joint replacements (e.g., hip or knee implants), cardiovascular implants (e.g., stents or pacemakers), dental implants, and various orthopedic devices. They often provide long-term solutions to medical conditions and are integrated into the body's anatomical structures through surgical procedures.

Breakup by End User:

Ambulatory Surgical Centers

Clinics

Hospital

Others

Hospitals are the leading end users in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes ambulatory surgical centers, clinics, hospital, and others. According to the report, hospitals accounted for the largest market share.

Hospitals house a diverse range of medical specialists, including surgeons, orthopedists, cardiologists, and dentists. These experts are trained to diagnose, recommend, and perform surgical procedures that involve the use of bio-implants. The presence of skilled healthcare professionals ensures that implants are correctly selected, implanted, and monitored for optimal patient outcomes. Moreover, hospitals are equipped with state-of-the-art surgical facilities, including operating rooms, advanced imaging technologies, and post-operative care units. These facilities are essential for performing complex implant surgeries safely and efficiently, ensuring the best possible results for patients.

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to the report, North America accounted for the largest market share.

North America boasts a well-developed and advanced healthcare infrastructure, including modern hospitals, research institutions, and medical universities. This infrastructure supports the adoption of innovative medical technologies, including bio-implants, and facilitates their integration into clinical practice. Moreover, the region's substantial healthcare expenditure allows for significant investments in medical research, technology, and patient care. This financial commitment enables healthcare providers to offer a wide range of advanced medical interventions, including bio-implants, to patients. Besides, stringent regulatory standards and thorough approval processes ensure the safety and efficacy of medical devices, including bio-implants, in North America. This regulatory framework instills confidence among healthcare professionals and patients, promoting the adoption of bio-implant technologies.

Competitive Landscape:

The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are investing significantly in R&D to develop advanced bio-implants that incorporate cutting-edge technologies, biomaterials, and design methodologies. These developments aim to improve implant durability, biocompatibility, and functionality. They are also expanding their product offerings to cover a broader spectrum of medical needs. This includes developing a range of bio-implants for different anatomical sites, medical conditions, and patient demographics. Moreover, to meet individual patient requirements, some companies are focusing on offering personalized bio-implant solutions. They use techniques like 3D printing and computer-aided design to create implants tailored to a patient's unique anatomy and needs.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Boston Scientific Corporation

Stryker Corporation

St. Jude Medical Inc

Medtronic Inc.

Smith and Nephew

Wright Medical Group

Zimmer Biomet

Dentsply Sirona

Invibio Limited

Straumann

Danaher Corporation

Cardinal Health

Johnson & Johnson

B. Braun Melsungen

LifeNet Health, Inc

Endo International plc

Recent Developments:

Medtronic Inc. has introduced implantable devices that can communicate wirelessly with smartphones or other external devices, enabling patients and healthcare professionals to monitor and manage implant performance remotely.

Stryker corporation introduced a novel bio-implant for spinal fusion surgeries. This implant features an innovative design that enhances stability and promotes better fusion between vertebrae, addressing patients' needs for improved spinal health.

Zimmer Biomet developed a customizable knee implant system using 3D printing technology. This system allows surgeons to create patient-specific knee implants that match the patient's unique anatomy, potentially leading to better post-operative outcomes.

Key Questions Answered in This Report

  • 1. What was the size of the global bio-implants market in 2023?
  • 2. What is the expected growth rate of the global bio-implants market during 2024-2032?
  • 3. What are the key factors driving the global bio-implants market?
  • 4. What has been the impact of COVID-19 on the global bio-implants market?
  • 5. What is the breakup of the global bio-implants market based on the type of bio-implants?
  • 6. What is the breakup of the global bio-implants market based on the origin?
  • 7. What is the breakup of the global bio-implants market based on the end-user?
  • 8. What are the key regions in the global bio-implants market?
  • 9. Who are the key players/companies in the global bio-implants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bio-Implants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type of Bio-Implants
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Origin
  • 5.7 Market Breakup by Mode of Administration
  • 5.8 Market Breakup by End-User
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Type of Bio-Implants

  • 6.1 Cardiovascular Implants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dental Implants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Spinal Bio-implants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Orthopaedic Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Ophthalmic Implants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metallic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ceramic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Polymer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biological
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Origin

  • 8.1 Allograft
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autograft
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Xenograft
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Synthetic
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Mode of Administration

  • 9.1 Non Surgical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Surgical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgical Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Hospital
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Bio-Implants Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Bio-Implants Industry: Value Chain Analysis

  • 13.1 Overview
  • 13.2 Research and Development
  • 13.3 Raw Material Procurement
  • 13.4 Manufacturing
  • 13.5 Marketing
  • 13.6 Distribution
  • 13.7 End-Use

14 Global Bio-Implants Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Bio-Implants Industry: Price Analysis

  • 15.1 Price Indicators
  • 15.2 Price Structure
  • 15.3 Margin Analysis

16 Bio-Implants Manufacturing Process

  • 16.1 Product Overview
  • 16.2 Raw Material Requirements
  • 16.3 Manufacturing Process
  • 16.4 Key Success and Risk Factors

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
    • 17.3.2 Boston Scientific Corporation
    • 17.3.3 Stryker Corporation
    • 17.3.4 St. Jude Medical Inc
    • 17.3.5 Medtronic Inc.
    • 17.3.6 Smith and Nephew
    • 17.3.7 Wright Medical Group
    • 17.3.8 Zimmer Biomet
    • 17.3.9 Dentsply Sirona
    • 17.3.10 Invibio Limited
    • 17.3.11 Straumann
    • 17.3.12 Danaher Corporation
    • 17.3.13 Cardinal Health
    • 17.3.14 Johnson & Johnson
    • 17.3.15 B. Braun Melsungen
    • 17.3.16 LifeNet Health, Inc
    • 17.3.17 Endo International plc

List of Figures

  • Figure 1: Global: Bio-Implants Market: Major Drivers and Challenges
  • Figure 2: Global: Bio-Implants Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bio-Implants Market: Breakup by Type of Bio-Implants (in %), 2023
  • Figure 4: Global: Bio-Implants Market: Breakup by Material (in %), 2023
  • Figure 5: Global: Bio-Implants Market: Breakup by Origin (in %), 2023
  • Figure 6: Global: Bio-Implants Market: Breakup by Mode of Administration (in %), 2023
  • Figure 7: Global: Bio-Implants Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Bio-Implants Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Bio-Implants Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Bio-Implants Industry: SWOT Analysis
  • Figure 11: Global: Bio-Implants Industry: Value Chain Analysis
  • Figure 12: Global: Bio-Implants Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Bio-Implants (Cardiovascular Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Bio-Implants (Cardiovascular Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Bio-Implants (Dental Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Bio-Implants (Dental Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Bio-Implants (Spinal Bio-implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Bio-Implants (Spinal Bio-implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Bio-Implants (Orthopaedic Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Bio-Implants (Orthopaedic Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Bio-Implants (Ophthalmic Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Bio-Implants (Ophthalmic Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Bio-Implants (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Bio-Implants (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Bio-Implants (Metallic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Bio-Implants (Metallic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Bio-Implants (Ceramic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Bio-Implants (Ceramic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Bio-Implants (Polymer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Bio-Implants (Polymer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Bio-Implants (Biological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Bio-Implants (Biological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Bio-Implants (Allograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Bio-Implants (Allograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Bio-Implants (Autograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Bio-Implants (Autograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Bio-Implants (Xenograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Bio-Implants (Xenograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Bio-Implants (Synthetic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Bio-Implants (Synthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Bio-Implants (Non Surgical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Bio-Implants (Non Surgical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Bio-Implants (Surgical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Bio-Implants (Surgical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Bio-Implants (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Bio-Implants (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Bio-Implants (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Bio-Implants (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Bio-Implants (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Bio-Implants (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Bio-Implants (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Bio-Implants (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia Pacific: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia Pacific: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Middle East and Africa: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Middle East and Africa: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Bio-Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Bio-Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Bio-Implants Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Bio-Implants Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bio-Implants Market Forecast: Breakup by Type of Bio-Implants (in Million US$), 2024-2032
  • Table 3: Global: Bio-Implants Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Bio-Implants Market Forecast: Breakup by Origin (in Million US$), 2024-2032
  • Table 5: Global: Bio-Implants Market Forecast: Breakup by Mode of Administration (in Million US$), 2024-2032
  • Table 6: Global: Bio-Implants Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Bio-Implants Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Bio-Implants: Raw Material Requirements
  • Table 9: Global: Bio-Implants Market Structure
  • Table 10: Global: Bio-Implants Market: Key Players